BG
Bellevue Group Portfolio holdings
AUM
$4.54B
1-Year Return
22.5%
This Quarter Return
+0.51%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$9.85B
AUM Growth
-$390M
(-3.8%)
Cap. Flow
-$133M
Cap. Flow
% of AUM
-1.35%
Top 10 Holdings %
Top 10 Hldgs %
29.91%
Holding
226
New
13
Increased
56
Reduced
57
Closed
7
Top Buys
| 1 |
Sarepta Therapeutics
SRPT
|
$52.6M |
| 2 |
Revolution Medicines
RVMD
|
$44.1M |
| 3 |
SAGE
Sage Therapeutics
SAGE
|
$37.4M |
| 4 |
Fate Therapeutics
FATE
|
$37M |
| 5 |
AMED
Amedisys
AMED
|
$36.1M |
Top Sells
| 1 |
Moderna
MRNA
|
$314M |
| 2 |
Halozyme
HALO
|
$53M |
| 3 |
Charles River Laboratories
CRL
|
$47.4M |
| 4 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
$38M |
| 5 |
Bio-Rad Laboratories Class A
BIO
|
$30.8M |
Sector Composition
| 1 | Healthcare | 96.84% |
| 2 | Industrials | 0.82% |
| 3 | Technology | 0.59% |
| 4 | Financials | 0.04% |
| 5 | Consumer Discretionary | 0.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Sight Sciences
SGHT
$195M
| $6.81M | 0.07% |
+300,000
| New | +$6.81M |
|
127
Pulmonx
LUNG
$70.9M
| $6.35M | 0.06% |
176,510
| – | – |
|
128
Procept Biorobotics
PRCT
$2.13B
| $5.72M | 0.06% |
+150,000
| New | +$5.72M |
|
|
SYNH
129
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $4.99M | 0.05% |
57,000
-13,500
| -19% | -$1.18M |
|
130
Harmony Biosciences
HRMY
$2.09B
| $4.96M | 0.05% |
+129,289
| New | +$4.96M |
|
131
Johnson & Johnson
JNJ
$431B
| $4.93M | 0.05% |
30,500
-500
| -2% | -$80.8K |
|
|
CTLT
132
DELISTED
CATALENT, INC.
CTLT
| $4.79M | 0.05% |
36,000
+33,300
| +1,233% | +$4.43M |
|
|
OLK
133
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $4.79M | 0.05% |
197,527
| – | – |
|
134
Seer Inc
SEER
$114M
| $4.7M | 0.05% |
136,133
| – | – |
|
135
Pfizer
PFE
$140B
| $4.28M | 0.04% |
+99,600
| New | +$4.28M |
|
136
BioMarin Pharmaceuticals
BMRN
$10.9B
| $4M | 0.04% |
51,700
+11,200
| +28% | +$866K |
|
137
BioNTech
BNTX
$24.9B
| $3.47M | 0.04% |
12,700
-9,900
| -44% | -$2.7M |
|
|
MRTX
138
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $3.34M | 0.03% |
18,900
+11,600
| +159% | +$2.05M |
|
139
Novavax
NVAX
$1.27B
| $3.32M | 0.03% |
+16,000
| New | +$3.32M |
|
140
Arcus Biosciences
RCUS
$1.23B
| $3.3M | 0.03% |
94,700
+19,700
| +26% | +$687K |
|
141
Sanofi
SNY
$111B
| $3.23M | 0.03% |
67,000
-1,000
| -1% | -$48.2K |
|
|
BCYC
142
Bicycle Therapeutics
BCYC
$483M
| $2.73M | 0.03% |
+65,700
| New | +$2.73M |
|
143
Ultragenyx Pharmaceutical
RARE
$3.01B
| $2.52M | 0.03% |
27,900
+6,500
| +30% | +$586K |
|
|
BHVN
144
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $2.43M | 0.02% |
17,500
-18,500
| -51% | -$2.57M |
|
145
Intellia Therapeutics
NTLA
$1.25B
| $2.23M | 0.02% |
+16,594
| New | +$2.23M |
|
146
C4 Therapeutics
CCCC
$190M
| $2.11M | 0.02% |
47,200
+16,200
| +52% | +$724K |
|
147
Kymera Therapeutics
KYMR
$3.02B
| $2.09M | 0.02% |
+35,500
| New | +$2.09M |
|
148
CareDx
CDNA
$697M
| $1.96M | 0.02% |
30,943
-117,928
| -79% | -$7.47M |
|
|
ALLK
149
DELISTED
Allakos
ALLK
| $1.96M | 0.02% |
18,500
| – | – |
|
150
CureVac
CVAC
$1.2B
| $1.92M | 0.02% |
+35,200
| New | +$1.92M |
|